Kathleen Borthwick, CFO at Passage BIO, Inc. (PASG), sold 3,183 shares at $0.53 ($2K) on 2025-02-11, disclosed to the SEC on 2025-02-12.
Open-market sale of $2k PASG by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PASG | SELL | 2024-01-03 | $10K | — | Filing → |